Journal of Medicinal Chemistry
Article
lipoxygenase/leukocyte type 12-lipoxygenase in colorectal carcino-
genesis. Adv. Exp. Med. Biol. 1999, 469, 593−598. (e) Soriano, A. F.;
Helfrich, B.; Chan, D. C.; Heasley, L. E.; Bunn, P. A.; Chou, T. C.
Synergistic effects of new chemopreventive agents and conventional
cytotoxic agents against human lung cancer cell lines. Cancer Res. 1999,
59, 6178−6184.
inhibition; HTS, high-throughput screening; MLSMR, Molec-
ular Libraries Small Molecule Repository; qHTS, quantitative
high-throughput screening; PAR-4, protease-activated receptor-
4; EtOH, ethanol; MeOH, methanol; EtOAc, ethyl acetate;
AcOH, acetic acid; MW, microwave; Xantphos, 4,5-bis-
(diphenylphosphino)-9,9-dimethylxanthene; SD, standard de-
viation; MLPCN, Molecular Libraries Probe Production Center
Network
(11) (a) Nappez, C.; Liagre, B.; Beneytout, J. L. Changes in
lipoxygenase activities in human erythroleukemia (HEL) cells during
diosgenin-induced differentiation. Cancer Lett. 1995, 96, 133−140.
(b) Timar
melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE.
Int. J. Cancer 1993, 55, 1003−1010. (c) Honn, K. V.; Timar, J.; Rozhin,
́
, J.; Silletti, S.; Bazaz, R.; Raz, A.; Honn, K. V. Regulation of
REFERENCES
■
́
(1) Solomon, E. I.; Zhou, J.; Neese, F.; Pavel, E. G. New insights
from spectroscopy into the structure/function relationships of
lipoxygenases. Chem. Biol. 1997, 4, 795−808. (b) Brash, A. R.
Lipoxygenases: Occurrence, Functions, Catalysis and Acquisition of
Substrate. J. Biol. Chem. 1999, 274, 23679−23682.
J.; Bazaz, R.; Sameni, M.; Ziegler, G.; Sloane, B. A lipoxygenase
metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated
release of cathepsin B from malignant cells. Exp. Cell. Res. 1994,
214, 120−130. (d) Nie, D.; Tang, K.; Diglio, C.; Honn, K. Eicosanoid
regulation of angiogenesis: role of endothelial arachidonate 12-
lipoxygenase. Blood 2000, 95, 2304−2311.
(2) Serhan, C. N.; Petasis, N. A. Resolvins and Protectins in
Inflammation Resolution. Chem. Rev. 2011, 111, 5922−5943.
(3) (a) Ghosh, J. Inhibition of Arachidonate 5-Lipoxygenase Triggers
Prostate Cancer Cell Death through Rapid Activation of C-Jun N-
Terminal Kinase. Biochem. Biophys. Res. Commun. 2003, 307, 342−349.
(b) Ghosh, J.; Myers, C. E. Inhibition of Arachidonate 5-Lipoxygenase
Triggers Massive Apoptosis in Human Prostate Cancer Cells. Proc.
Natl. Acad. Sci. U. S. A. 1998, 95, 13182−13187. (c) Nakano, H.;
Inoue, T.; Kawasaki, N.; Miyataka, H.; Matsumoto, H.; Taguchi, T.;
Inagaki, N.; Nagai, H.; Satoh, T. Synthesis and Biological Activities of
Novel Antiallergic Agents with 5-Lipoxygenase Inhibiting Action.
Bioorg. Med. Chem. 2000, 8, 373−280.
(4) Nakano, H.; Inoue, T.; Kawasaki, N.; Miyataka, H.; Matsumoto,
H.; Taguchi, T.; Inagaki, N.; Nagai, H.; Satoh, T. Synthesis and
biological activities of novel antiallergic agents with 5-lipoxygenase
inhibiting action. Bioorg. Med. Chem. 2000, 8, 373−380.
(5) Berger, W.; De Chandt, M. T.; Cairns, C. B. Zileuton: Clinical
Implications of 5-Lipoxygenase Inhibition in Severe Airway Disease.
Int. J. Clin. Pract. 2007, 61, 663−676.
(6) (a) Cyrus, T.; Witztum, J. L.; Rader, D. J.; Tangirala, R.; Fazio, S.;
Linton, M. F.; Funk, C. D. Disruption of the 12/15-lipoxygenase gene
diminishes atherosclerosis in apo E-deficient mice. J. Clin. Invest. 1999,
103, 1597−1604. (b) Harats, D.; Shaish, A.; George, J.; Mulkins, M.;
Kurihara, H.; Levkovitz, H.; Sigal, E. Overexpression of 15-
lipoxygenase in vascular endothelium accelerates early atherosclerosis
in LDL receptor-deficient mice. Arteriosler. Thromb. Vasc. Biol. 2000,
20, 2100−2105.
(7) Pratico, D.; Zhukareva, V.; Yao, Y.; Uryu, K.; Funk, C. D.;
Lawson, J. A.; Trojanowski, J. Q.; Lee, V. M. 12/15-Lipoxygenase is
increased in Alzheimer’s disease: possible involvement in brain
oxidative stress. Am. J. Pathol. 2004, 164, 1655−1662.
(8) (a) van Leyen, K.; Arai, K.; Jin, G.; Kenyon, V.; Gerstner, B.;
Rosenberg, P. A.; Holman, T. R.; Lo, E. H. Novel lipoxygenase
inhibitors as neuroprotective reagents. J. Neurosci. Res. 2008, 86, 904−
909. (b) van Leyen, K.; Kim, H. Y.; Lee, S. R.; Jin, G.; Arai, K.; Lo, E.
H. Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke
2006, 37, 3014−3018.
(9) Yamamoto, S. Mammalian lipoxygenases: Molecular Structures
and functions. Biochim. Biophys. Acta 1992, 1128, 117−131. (b) Funk,
C. D.; Keeney, D. S.; Oliw, E. H.; Vogel, S.; Muller-Decker, K.;
Mincheva, A.; Lichter, P.; Marks, F.; Krieg, P. Murine epidermal
lipoxygenase (Aloxe) encodes a 12-lipoxygenase isoform. FEBS Lett.
1997, 402, 162−166.
(12) (a) McDuffie, M.; Maybee, N. A.; Keller, S. R.; Stevens, B. K.;
Garmey, J. C.; Morris, M. A.; Kropf, E.; Rival, C.; Ma, K.; Carter, J. D.;
Tersey, S. A.; Nunemaker, C. S.; Nadler, J. L. Nonobese diabetic
(NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase
are protected from autoimmune diabetes. Diabetes 2008, 57, 199−209.
(b) Bleich, D.; Chen, S.; Zipser, B.; Sun, D.; Funk, C. D.; Nadler, J. L.
Resistance to type 1 diabetes induction in 12-lipoxygenase knockout
mice. J. Clin. Invest. 1999, 103, 1431−1436. (c) Imai, Y.; Dobrian, A.
D.; Weaver, J. R.; Butcher, M. J.; Cole, B. K.; Galkina, E. V.; Morris, M.
A.; Taylor-Fishwick, D. A.; Nadler, J. L. Interaction between cytokines
and inflammatory cells in islet dysfunction, insulin resistance and
vascular disease. Diabetes Obes. Metab. 2013, 15 (Suppl 3), 117−129.
(d) Ma, K.; Nunemaker, C. S.; Wu, R.; Chakrabarti, S. K.; Taylor-
Fishwick, D. A.; Nadler, J. L. 12-Lipoxygenase Products Reduce Insulin
Secretion and β-Cell Viability in Human Islets. J. Clin. Endocrinol.
Metab. 2010, 95, 887−893.
(13) Chen, M.; Yang, Z. D.; Smith, K. M.; Carter, J. D.; Nadler, J. L.
Activation of 12-Lipoxygenase in proinflammatory cytokine-mediated
β-cell toxicity. Diabetologia 2005, 48, 486−495.
(14) (a) Brash, A. R. A review of possible roles of the platelet 12-
lipoxygenase. Circulation 1985, 72, 702−707.
(15) (a) Aharony, D.; Smith, J. B.; Silver, M. J. Regulation of
arachidonate-induced platelet aggregation by the lipoxygenase product,
12-hydroperoxyeicosatetraenoic acid. Biochim. Biophys. Acta 1982, 718,
193−200. (b) Chang, J.; Blazek, E.; Kreft, A. F.; Lewis, A. J. Inhibition
of platelet and neutrophil phospholipase A2 by hydroxyeicosate-
traenoic acids (HETES). A novel pharmacological mechanism for
regulating free fatty acid release. Biochem. Pharmacol. 1985, 34, 1571−
1575. (c) Nyby, M. D.; Sasaki, M.; Ideguchi, Y.; Wynne, H. E.; Hori,
M. T.; Berger, M. E.; Golub, M. S.; Brickman, A. S.; Tuck, M. L.
Platelet lipoxygenase inhibitors attenuate thrombin-and thromboxane
mimetic-induced intracellular calcium mobilization and platelet
aggregation. J. Pharmacol. Exp. Ther. 1996, 278, 503−509.
(16) Kenyon, V.; Rai, G.; Jadhav, A.; Schultz, L.; Armstrong, M.;
Jameson, J. B.; Perry, S.; Joshi, N.; Bougie, J. M.; Leister, W.; Taylor-
Fishwick, D. A.; Nadler, J. L.; Holinstat, M.; Simeonov, A.; Maloney,
D. J.; Holman, T. R. Discovery of Potent and Selective Inhibitors of
Human Platelet-Type 12-Lipoxygenase. J. Med. Chem. 2011, 54,
5485−5497.
(17) Yeung, J.; Apopa, P. L.; Vesci, J.; Kenyon, V.; Rai, G.; Jadhav, A.;
Simeonov, A.; Holman, T. R.; Maloney, D. J.; Boutaud, O. Holinstat.
Protein Kinase C Regulation of 12-Lipoxygenase-Mediated Human
Platelet Activation. Mol. Pharmacol. 2012, 81, 420−430.
(18) (a) Whitman, S.; Gezginci, M.; Timmermann, B. N.; Holman,
T. R. Structure−activity relationship studies of nordihydroguaiaretic
acid inhibitors toward soybean, 12-human, and 15-human lip-
oxygenase. J. Med. Chem. 2002, 45, 2659−2661. (b) Deschamps, J.
D.; Kenyon, V. A.; Holman, T. R. Baicalein is a potent in vitro
inhibitor against both reticulocyte 15-human and platelet 12-human
lipoxygenases. Bioorg. Med. Chem. 2006, 14, 4295−4301. (c) Segraves,
E. N.; Shah, R. R.; Segraves, N. L.; Johnson, T. A.; Whitman, S.; Sui, J.
(10) (a) Catalano, A.; Procopio, A. New aspects on the role of
lipoxygenases in cancer progression. Histol. Histopathol. 2005, 20,
969−975. (b) Nie, D.; Hillman, G. G.; Geddes, T.; Tang, K.; Pierson,
C.; Grignon, D. J.; Honn, K. V. Platelet-type 12-lipoxygenase in a
human prostate carcinoma stimulates angiogenesis and tumor growth.
Cancer Res. 1998, 58, 4047−4051. (c) Natarajan, R.; Esworthy, R.; Bai,
W.; Gu, J. L.; Wilczynski, S.; Nadler, J. L. Increase 12-lipoxygenase
expression in breast cancer cells and tissues. Regulation by epidermal
growth factor. J. Clin. Endocrinol. Metab. 1997, 82, 1790−1798.
(d) Kamitani, H.; Geller, M.; Eling, T. The possible involvement of 15-
505
dx.doi.org/10.1021/jm4016476 | J. Med. Chem. 2014, 57, 495−506